PolyPeptide rallies over 5% as Samsung Biologics strikes $1.8 billion deal

Investing.com•Mon, Jul 20, 2026, 07:43 AM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/stock-market-news/samsung-biologics-falls-3-after-18-billion-polypeptide-acquisition-4799785)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #polypeptide #rallies #samsung #biologics #strikes #billion #deal

More Headlines

SportsYahoo Sports• 7m ago

Former Washington star signs one-year deal with Los Angeles Lakers

Former Washington Huskies star Matisse Thybulle has found his next destination in the NBA after inking a one-year contract on Monday.

FinanceBloomberg Markets• 10m ago

Australia’s Stock Market Emerges as Haven From Volatile AI Trade

Australia’s stock market has emerged as an unlikely haven from the artificial intelligence-driven volatility that has roiled Asian equities in recent months.

FinanceSeeking Alpha• 13m ago

Mega IPOs - A Sign Of The End?

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 17m ago

Analog Devices: Shares Are Almost Too Expensive

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 20m ago

Gold Steady as Traders Watch Middle East War for Inflation Clues

Gold was steady as traders monitored a raft of developments in the Middle East conflict for clues on the energy price impact on inflation.

FinanceInvesting.com• 25m ago

Twenty-seven bodies recovered after ferry capsizes off Guyana

Developing story — details emerging. Check the source link for the latest updates.